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Dietary folate and vitamin B6 are independent
predictors of peripheral arterial occlusive disease
Antonius B. M. Wilmink, MD,a Ailsa A. Welch, MSc,b Clive R. G. Quick, MS,c Paul J. Burns, MBBS,a
C. S. Hubbard, MD,d Andrew W. Bradbury, MD,a and Nicholas E. Day, PhD,e Birmingham, Cambridge,
and Huntingdon, United Kingdom
Background: It has been suggested that hyperhomocysteinemia (HHcy) is an independent risk factor for peripheral
arterial occlusive disease (PAOD). However, the relationship between dietary folate and vitamin B6, cofactors in the
metabolism of homocysteine (Hcy), and PAOD is unclear.
Aims: To study the relationship between dietary folate and B6 and PAOD.
Methods: Case–control population based study of 392 men older than 50 years living in Huntingdon, United Kingdom.
PAOD, defined as an ankle-brachial pressure index (ABPI) < 0.9, was present in 86 (22%) of subjects. Folate, vitamin B6,
and vitamin B12 intakes were calculated by means of the EPIC (European Prospective Investigation into Cancer) food
frequency questionnaire.
Results: Daily folate intake was significantly lower in case subjects (mean, 288; 95% confidence interval [CI], 266-309g)
than in control subjects (324; 95% CI, 313-335 g). Daily vitamin B6 intake was also lower in case subjects (2.05; 95%
CI, 1.92-2.19 mg versus 2.26; 95% CI, 2.19-2.33 mg). Daily folate and vitamin B6 intakes were independent predictors
of PAOD after adjusting for age, blood pressure, cholesterol levels, diabetes, and smoking status in a logistic regression
model. This model suggests that increasing daily folate intake by 1 standard deviation decreased the risk of PAOD by 46%.
A similar increase in daily vitamin B6 intake decreased the risk of PAOD by 29%.
Conclusion: In men older than 50 years, dietary folate and B6 intakes are independent predictors of PAOD. Longitudinal
studies are required to determine whether dietary modification can reduce the incidence of PAOD in the population. (J
Vasc Surg 2004;39:513-6.)
It is widely believed that hyperhomocysteinemia
(HHcy) is a risk factor for vascular disease.1-4 Homocys-
teine (Hcy) is derived from methionine and is metabolized
by cystathionine-synthase (CS) to cystathionine or rem-
ethylated to methionine. CS activity is dependent on vita-
min B6, whereas remethylation is dependent on vitamin
B12 and folate.5 Plasma Hcy is influenced by both genetic
and environmental factors. Inherited enzymatic defects can
lead to marked increases in Hcy but are relatively uncom-
mon.2,6 By contrast, nutritional deficiency usually leads to
only a modest elevation in Hcy but could be of greater
overall importance in the development of vascular disease
because of the prevalence of the condition, especially in the
older adults and lower socioeconomic groups. Plasma Hcy
correlates inversely with plasma folate, vitamin B6, and
vitamin B12 levels.7,8 Epidemiologic studies have sug-
gested an association between poor vitamin B6 and folate
intakes and coronary heart disease.5,9 However, the rela-
tionship between diet, plasma Hcy. and peripheral arterial
occlusive disease (PAOD) is unclear. The aim of this study,
therefore, was to examine the relationship with dietary
folate, vitamin B6, and vitamin B12 intakes in a cohort of
men aged older than 50 years recruited from a population-
based abdominal aortic aneurysm (AAA) screening pro-
gram.
METHODS
A subset of 392 men older than 50 years attending the
Huntingdon AAA screening program were studied for a
study into small aneurysms.10 All subjects in that study had
their ankle-brachial pressure index (ABPI) measured as part
of the medical examination. In the group of 392 men 86
had evidence of PAOD as defined by an ABPI  0.9, and
306 men had a normal ABPI. A case subject was defined as
a person with an ABPI  0.9 and a control subject as a
person with an ABPI  0.9. These participants formed the
population for this study into the relationship between diet
and PAOD. No age matching was used. All subjects com-
pleted a self-administered questionnaire about smoking
and previous medical and drug history. Height, weight,
blood pressure (Dinamap 1846 SXP; Critikon, Kettering,
United Kingdom), and ABPI were measured by the same
observer. ABPI was performed in the supine position with
the use of a hand-held Doppler scan (Mini Dopplex D900;
Huntleigh Diagnostics, Cardiff, United Kingdom) with an
8-MHz probe and a standard sphygmomanometer. Blood
was drawn for a lipid profile. Nutritional information was
collected by using the food-frequency questionnaire (FFQ)
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developed by the European Prospective Investigation into
Cancer (EPIC) Norfolk study.11,12 Briefly, the question-
naire asks the subjects to score how often on average they
have taken each of 130 different food items over the
previous year (Table I). The calculations were performed
by the EPIC-Norfolk group in Cambridge by using specif-
ically developed programs and databases that allow conver-
sion of questionnaire data into nutrient estimates. The food
databases associated with each program are based on pub-
lished food-composition tables, which are frequently up-
dated with nutrient data on new food items. Nutrient
intakes for the FFQ were calculated by multiplying the
frequency of consumption of food items by standard por-
tion weights to derive an estimate of grams of food con-
sumed per day. The food items were converted into nutri-
ents by using the appropriate food-table codes.10-13 The
association between PAOD and the most common micro-
nutrients, such as all vitamins and fatty acids, and the most
common minerals, such as iron, zinc, magnesium, copper,
and selenium, were investigated.
Statistical analysis. Levels of micronutrient intakes of
case subjects and control subjects were examined by com-
paring adjusted mean values and by calculating odds ratios
over quartiles of micronutrient intakes with the use of linear
and logistic regression methods14,15 (STATA 5.0 for
Macintosh; Stata Corporation, College Station, Tex).
Mean micronutrient intakes in case subjects and control
subjects were compared by using Student t test and the
Fisher F test. Vitamin B12 intake was logarithmically trans-
formed because of its skewed distribution. The association
between micronutrient intakes and PAOD was investigated
further by estimating the odds ratio over quartiles of mi-
cronutrient intakes in a logistic regression model after
adjusting for age, cholesterol level, smoking status, and
blood pressure.
RESULTS
Case subjects with PAOD (n  86) were significantly
different from the 306 control subjects in terms of age,
weight, blood pressure, cholesterol levels, and smoking
status (Table II). Daily vitamin B12 intake varied more
than daily folate and vitamin B6 intakes (Table III). Daily
folate and vitamin B6 intakes, but not vitamin B12 intake,
were significantly lower in case subjects than in control
subjects (Table II). These differences remained after adjust-
ing for relevant confounders (Table IV). Age, systolic
blood pressure, smoking status, and cholesterol levels were
independent predictors for the risk of PAOD in multivari-
ate analysis (Table V). We adjusted for these relevant con-
founders when we examined the effect of folate, vitamin
B6, and vitamin B12 intakes on the risk of PAOD. We
found that daily folate and vitamin B6 intakes were inde-
pendently associated with risk of PAOD in a logistic regres-
sion model that adjusted for age, blood pressure, choles-
terol levels, diabetes, and smoking status (Table VI). There
was a relationship between the level of daily folate and B6
intakes and the prevalence of PAOD. The risk of PAOD in
the quartile of men with the highest folate and B6 intakes
was one third compared with men in the quartile with the
lowest intake.
DISCUSSION
The principal novel finding of the present study is that
in men older than 50 years attending an AAA screening
program, the presence of PAOD, as defined by an ABPI of
 0.9, is associated with a significantly lower daily intake of
folate and vitamin B6 but not vitamin B12. FFQs generally
produce estimates of nutrient intake that are higher than
the other methods available.12,13 The EPIC FFQ has been
extensively validated in the Norfolk cohort: a population
very similar to the population in the Huntingdon district.
The reproducibility of the FFQ in that study was moderate
to high with correlation coefficients of 0.5 to 0.8.11 No
specific validation data of folate and B-vitamin intakes are
available. However, the FFQ performed as well as a more
labor-intensive seven-day food dairy in estimating the vita-
min C intake.11 We believe that lack of vitamin B–specific
validation data does not bias the results of this study,
because the EPIC FFQ is widely used and the same method
of micronutrient intake estimation was used for case sub-
jects and control subjects. The main dietary contributors to
folate and vitamin B6 are vegetables, potatoes, and cereal
foods, including bread and breakfast cereals. Milk and meat
are also important sources of vitamin B6. We did find that
an increased intake of meat and fruits and vegetables was
associated with a significantly reduced risk of PAOD after
adjusting for the standard risk factors. A healthier diet is
thought to reduce the risk of PAOD. The Hcy pathway
could be one of the biological explanations for the associ-
ation between diet and PAOD, but other biochemical
pathways might be relevant, too. There were no statistically
significant differences between exercise levels and PAOD.
In contrast to folate, most diets contain adequate vita-
min B12 intake with a median daily intake of 5 g/day.16
Our estimates for vitamin B12 intake are similar to pub-
lished figures.16 This similarity could explain our finding
that dietary vitamin B12 was not associated with PAOD.
Our study suggests that an increase in daily vitamin B6
intake of 1 mg is associated with a decreased risk of PAOD
(odds ratio [OR], 0.53; 95% confidence interval [CI],
Table I. Categories in the EPIC food-frequency
questionnaire
Food frequency category Score
Never or less than once per month 1
One to three times per month 2
Once per week 3
Two to four times per week 4
Five or six times per week 5
Once per day 6
Two or three times per day 7
Four or five times per day 8
More than 6 times per day 9
Subjects were asked to indicate how often, on average, they took the
specified amount of each of 130 food items during the last year.
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0.33-0.86). Our estimates suggest that a 1-g increase in
daily folate intake is associated with a decreased risk of
PAOD by approximately 0.5% (OR, 0.995; 95% CI, 0.993-
0.998). This means that an increase in the daily intake of
folic acid by one standard deviation (approximately 100 g
per day) is associated with an almost 50% reduction in the
risk of PAOD. An increase in the daily intake of vitamin B6
by one standard deviation (approximately 0.5 mg per day)
would reduce the risk of PAOD by 29%. Our model sug-
gests that doubling the daily intake of vitamin B6 (from 1 to
2 mg) and doubling the daily folate intake (from 100 to
200g) for men in the lowest intake quartile would approx-
imately halve the prevalence of PAOD in this population.
Folate and vitamin B6 are essential cofactors in the
metabolism of Hcy metabolism, and low plasma folate and
B6 levels are associated with Hhcy.5-7 It is widely believed
that HHcy is an independent risk factor for the develop-
ment of arterial disease, although the exact mechanism
by which Hcy might exert this effect remains controver-
sial.1-3,7,8
What are the possible weaknesses in the present study?
First, plasma Hcy, folate, and B6 levels are not yet available
from this cohort, and so the association between diet,
HHcy, and PAOD remains indirect at this stage. Case–
control studies are also more prone to bias than are pro-
spective cohort studies. However, in this study, selection
bias was minimized as case and control subjects were de-
rived from the same population. Observer bias was also
minimized because the micronutrient intake was calculated
by an independent group unaware of whether the subject
was a case or control. Furthermore, a single observer blind
to the results of the dietary questionnaire performed all the
clinical examinations. The possible link between diet and
PAOD is important because present data suggest that quite
Table IV. Adjusted mean daily folate, vitamin B6, and
vitamin B12 intakes
Case subjects Control subjects
PMean 95% CI Mean 95% CI
Folate, g/d 288 266-309 324 313-335 .004
Vitamin B6,
mg/d
2.05 1.92-2.19 2.26 2.19-2.33 .007
Vitamin B12,
g/d
7.27 6.33-8.21 6.87 6.38-7.35 .46
Values have been adjusted for age, weight, smoking status, total cholesterol
levels and systolic and diastolic blood pressure by using linear regression
estimates.
Table V. ORs and 95% CIs of the standard risk factors
for peripheral arterial occlusive disease (PAOD) in the
study group
Variable OR 95% CI P
Age, y 1.09 1.05-1.14 .0001
Systolic BP 1.01 1.00-1.03 .05
Diastolic BP 1.00 0.97-1.03 .87
Current smoker 5.27 1.55-17.9 .01
Ex-smoker 2.59 0.84-8.0 .10
Total cholesterol 1.20 0.75-1.91 .45
LDL cholesterol 0.91 0.57-1.46 .69
HDL cholesterol 0.78 0.61-0.99 .045
Diabetes 0.95 0.19-4.68 .95
BP, Blood pressure.
Table II. Comparison of case and control subjects
Variable Case subjects Control subjects P
Number 86 306
Age, y (range) 73.5 (56-85) 69.9 (54-88) .0001
Height, cm (SD) 172.5 (6.4) 173.6 (6.7) .15
Weight, kg (SD) 77.1 (11.1) 80.8 (12.2) .01
BMI (SD) 25.9 (3.4) 26.7 (3.4) .04
Systolic BP, mmHg (SD) 163.1 (26.3) 153.3 (22.7) .0007
Diastolic BP, mmHg (SD) 87.2 (15.9) 83.5 (14.2) .04
Total cholesterol, mmol/L (SD) 6.1 (1.06) 5.8 (1.04) .03
HDL-Chol, mmol/L (SD) 1.11 (0.33) 1.17 (0.54) .33
LDL-Chol, mmol/L (SD) 4.08 (0.95) 3.81 (0.90) .02
Smoking status
Current 27% 19%
Ex-smoker 68% 66% .02
Nonsmoker 5% 15%
Folate intake, g/d (SD) 292 (84) 324 (99) .006
Vitamin B6 intake, mg/d (SD) 2.09 (0.56) 2.27 (0.63) .015
Vitamin B12 intake, mg/d (SD) 7.17 (5.17) 6.83 (3.65) .89
Mean values have been compared by Students t test and proportions by Fisher exact test.
BMI, Body mass index; BP, blood pressure; LDL-Chol, low density cholesterol; HDL-Chol, high density lipoprotein cholesterol.
Table III. Quartiles of mean daily folate, vitamin B6, and
vitamin B12 intakes in the study group
Nutrient
Quartile
1
Quartile
2
Quartile
3
Quartile
4
Folate, g/d 206 281 337 447
Vitamin B6, mg/d 1.6 2.0 2.4 3.0
Vitamin B12, g/d 3.7 5.3 7.0 11.3
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modest levels of dietary modification could have significant
effects. Moving from lowest quartile of intake to the second
quartile could result in a 32% reduction in POAD. This
reduction is especially important, because these results have
been obtained from dietary intake study and none of the
current intervention trials with supplements have had pos-
itive outcomes. However, longitudinal studies are required
to determine whether, indeed, this is the case.
CONCLUSION
Dietary folate and vitamin B6 intakes are independent
predictors of PAOD. Increasing dietary folate and vitamin
B6 in men with the lowest intake of these nutrients could
reduce the risk of PAOD.
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Table VI. Odds ratios and 95% CIs for each quartile of dietary folate, vitamin B6, and vitamin B12 compared with the
quartile with lowest daily intake
Micronutrient
Quartile 2
(95% CI)
Quartile 3
(95% CI)
Quartile 4
(95% CI)
Test for
trend
Total folate 0.68 (0.31-1.46) 0.65 (0.29-1.45) 0.31 (0.13-0.73) .002
Vitamin B6 0.89 (0.41-1.93) 1.18 (0.55-2.49) 0.29 (0.12-0.74) .04
Vitamin B12 0.73 (0.33-1.62) 0.90 (0.40-2.0) 0.98 (0.46-2.15) .90
The dietary variables were compared by using a logistic regression model that adjusted for age, blood pressure, smoking status, diabetes, and total cholesterol
level. Test for trend was calculated by referring the log likelihood ratio to a chi square distribution with the variable of interest as a continuous variable.
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